Hypomethylating Agent Therapy Use and Survival in Older Patients with Higher Risk Myelodysplastic Syndromes in USA: A Large Population-Based Study

2017 ◽  
Vol 55 ◽  
pp. S75-S76
Author(s):  
A. Zeidan ◽  
X. Hu ◽  
J.B. Long ◽  
R. Wang ◽  
S.F. Huntington ◽  
...  
2013 ◽  
Vol 9 (2) ◽  
pp. 92-98 ◽  
Author(s):  
Benjamin A. Spencer ◽  
Russell B. McBride ◽  
Dawn L. Hershman ◽  
Donna Buono ◽  
Harry W. Herr ◽  
...  

This large population-based study found improved OS and bladder cancer–specific survival associated with use of adjuvant intravesical BCG among older patients with NMIBC.


2020 ◽  
Vol 8 (7) ◽  
pp. 482-482 ◽  
Author(s):  
Jin-Feng Huang ◽  
Jianfei Shen ◽  
Xiao Li ◽  
Ramesh Rengan ◽  
Nicola Silvestris ◽  
...  

Cephalalgia ◽  
2000 ◽  
Vol 20 (4) ◽  
pp. 244-251 ◽  
Author(s):  
K Hagen ◽  
J-A Zwart ◽  
L Vatten ◽  
LJ Stovner ◽  
G Bovim

We have assessed the validity and reliability of a self-administered headache questionnaire used in the 'Nord-Trøndelag Health Survey 1995-97 (HUNT)' in Norway, by blindly comparing questionnaire-based headache diagnoses with those made in a clinical interview of a sample of the participants. Restrictive questionnaire-based diagnostic criteria for migraine, assessed according to modified criteria of the International Headache Society, performed excellently in selecting 'definite' migraine patients (100% positive predictive value). The best agreement concerning migraine diagnoses was achieved by using a liberal set of criteria (k 0.59). Similar agreement was found evaluating patient status as headache sufferers, and as sufferers from frequent headaches (>6 days per month) (k 0.57 and 0.50, respectively). The k values of nonmigrainous headache and chronic headache (>14 days per month) were 0.43 and 0.44, respectively. The results suggest that our self-administered questionnaire may be suitable in identifying a population with 'definite' migraine, and the questionnaire is an acceptable instrument in determining the prevalence in Nord-Trøndelag of headache sufferers, migraine, non-migrainous headache, and frequent or chronic headache sufferers.


Sign in / Sign up

Export Citation Format

Share Document